IdentificationGeneric Name(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-olDrugBank Accession NumberDB07711BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol (DB07711)× CloseWeightAverage: 277.3653 Monoisotopic: 277.190260383 Chemical FormulaC14H23N5OSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUAdenosine deaminaseNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassImidazopyrimidinesSub ClassPurines and purine derivativesDirect Parent6-aminopurinesAlternative ParentsAminopyrimidines and derivatives / N-substituted imidazoles / Imidolactams / Heteroaromatic compounds / Secondary alcohols / Azacyclic compounds / Primary amines / Organopnictogen compounds / Hydrocarbon derivativesSubstituents6-aminopurine / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Heteroaromatic compound / Hydrocarbon derivative / ImidazoleMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsEHNA (CHEBI:63059) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyIOSAAWHGJUZBOG-WDEREUQCSA-NInChIInChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1IUPAC Name(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-olSMILES[H][C@@](C)(O)[C@@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound149790PubChem Substance99444182ChemSpider132030BindingDB28393ChEBI63059ChEMBLCHEMBL296435ZINCZINC000001558334PDBe LigandEH9PDB Entries2z7g / 4c1iClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.44 mg/mLALOGPSlogP2.1ALOGPSlogP2.14ChemaxonlogS-2.8ALOGPSpKa (Strongest Acidic)14.8ChemaxonpKa (Strongest Basic)3.7ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area89.85 Å2ChemaxonRotatable Bond Count7ChemaxonRefractivity79.55 m3·mol-1ChemaxonPolarizability31.05 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9937Blood Brain Barrier+0.8503Caco-2 permeable-0.5891P-glycoprotein substrateSubstrate0.6841P-glycoprotein inhibitor INon-inhibitor0.9067P-glycoprotein inhibitor IIInhibitor0.5468Renal organic cation transporterNon-inhibitor0.746CYP450 2C9 substrateNon-substrate0.8684CYP450 2D6 substrateNon-substrate0.8054CYP450 3A4 substrateNon-substrate0.6184CYP450 1A2 substrateNon-inhibitor0.7691CYP450 2C9 inhibitorNon-inhibitor0.907CYP450 2D6 inhibitorNon-inhibitor0.9231CYP450 2C19 inhibitorNon-inhibitor0.9026CYP450 3A4 inhibitorNon-inhibitor0.8309CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.5795Ames testNon AMES toxic0.5475CarcinogenicityNon-carcinogens0.8999BiodegradationNot ready biodegradable0.9923Rat acute toxicity2.6773 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8181hERG inhibition (predictor II)Non-inhibitor0.7205  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesKi (nM)2N/AN/AA28548


 Details


 Binding Properties1. Adenosine deaminaseKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionCatalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, an...Gene NameADAUniprot IDP00813Uniprot NameAdenosine deaminaseMolecular Weight40764.13 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 